Moreover, serum FABP4 levels were shown to be significantly the highest in the GDM group in the early puerperium, which may suggest that elevated FABP4 levels may persist in GDM patients postpartum and contribute to increased risk of T2DM and metabolic syndrome [147]. Here, FABP4 is linked to type 2 diabetes mellitus.